What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
. N Engl J Med. 2021 Sep 9;385(11):1018-1032. doi: 10.1056/NEJMra2101555. N Engl J Med. 2021. PMID: 34496176 Review.
.
Item in Clipboard